ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Testicle Size: Testosterone Injections vs hCG vs T gel
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 193004" data-attributes="member: 13851"><p><strong>*</strong><u><strong>Increase in TV was higher in the hCG group compared with both TE and TG groups</strong></u><strong>; but, there was no difference between TE and TG groups regarding a change in TV.</strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>Results </strong></p><p><strong></strong></p><p><strong>Baseline characteristics T</strong></p><p></p><p>The demographic and biochemical features of <strong>patients (n = 77)</strong> <strong>and healthy controls (n = 42) are displayed in Table 1.</strong> The two groups were similar with regard to age and BMI. Fasting plasma glucose and HOMA-IR levels were higher,<strong> whereas serum haemoglobin, haematocrit, creatinine, FSH, LH, TT, TS and <u>mean TV were significantly lower in patients with IHH </u>(P < 0.05, for all). </strong>LDL-cholesterol level of the control group was significantly higher than the patient group (P = 0.003). Of the 77 men in the study population, 17 (22.4%) had anaemia at baseline, with no evident cause. However, leucocyte counts, platelet count, total cholesterol, HDL cholesterol, triglyceride, AST, ALT and urea levels were similar in the two groups (Table 1).<strong> <u>Among the three subgroups of treatment, baseline values</u> for BMI and age, biochemical parameters and <u>m<strong>ean TV </strong>were also similar </u>(Table 1).</strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>Baseline vs post-treatment demographics, biochemical parameters, TS and TV</strong></p><p><strong></strong></p><p><strong><u>Subjects treated with TE were found to have significantly increased</u> </strong>BMI, haemoglobin, haematocrit, triglyceride, TT, creatinine, TS and<strong> <u>mean TV</u>, </strong>and decreased urea and HDL cholesterol levels by the 24th week (P < 0.05, for all) (Table 2; Fig. 1).</p><p></p><p>Mean plasma triglyceride decreased, whereas LH, TS and<strong> <u>TV increased significantly after hCG treatment</u> </strong>(P < 0.05, for all) (Table 2; Fig. 1). No significant changes in BMI or other biochemical parameters were observed in this group after 24 weeks.</p><p></p><p>Application of TG was associated with a significant increase in TT level, but within the normal range. Besides, BMI, LH, TS and <u><strong>mean TV increased</strong></u><strong>, </strong>and total cholesterol and HDL cholesterol levels decreased significantly in the same subgroup (P < 0.05, for all). Other tested parameters were similar before and after treatment (Table 2).</p><p></p><p></p><p></p><p></p><p><strong>Comparisons for the magnitude of the alterations in tested parameters among the study groups by the 24th week</strong></p><p></p><p>The number of changes in each tested parameter before and after the treatment was simply calculated by subtracting the pretreatment values from post-treatment ones. Then, intergroup differences were determined statistically (Table 3; Fig. 2).</p><p></p><p><strong>The number of changes in each tested parameter before and after the treatment was simply calculated by subtracting the pretreatment values from post-treatment ones. Then, intergroup differences were determined statistically (Table 3; Fig. 2). </strong>Leucocyte count reduced in TG-treated individuals, while it was found increased in the other two treatment types, and the difference between the TG and TE groups was significant. Haematocrit count increased much lower in the hCG-treated group, which was significant when compared with TE-treated group. hCG treatment resulted in a decrease in plasma triglyceride level, whereas it was found higher in the other two groups, and the differences were significant. TG treatment caused a significant increase in FSH, LH and testosterone levels compared with TE treatment. Increase in testosterone level was significantly higher in the TG-treated group in comparison with the other two groups. Increase in TS was significantly higher in the TE and TG treatment groups. <strong><u>Increase in TV was higher in the hCG group compared with both TE and TG groups</u>; but, there was no difference between TE and TG groups regarding a change in TV.</strong></p></blockquote><p></p>
[QUOTE="madman, post: 193004, member: 13851"] [B]*[/B][U][B]Increase in TV was higher in the hCG group compared with both TE and TG groups[/B][/U][B]; but, there was no difference between TE and TG groups regarding a change in TV. Results Baseline characteristics T[/B] The demographic and biochemical features of [B]patients (n = 77)[/B] [B]and healthy controls (n = 42) are displayed in Table 1.[/B] The two groups were similar with regard to age and BMI. Fasting plasma glucose and HOMA-IR levels were higher,[B] whereas serum haemoglobin, haematocrit, creatinine, FSH, LH, TT, TS and [U]mean TV were significantly lower in patients with IHH [/U](P < 0.05, for all). [/B]LDL-cholesterol level of the control group was significantly higher than the patient group (P = 0.003). Of the 77 men in the study population, 17 (22.4%) had anaemia at baseline, with no evident cause. However, leucocyte counts, platelet count, total cholesterol, HDL cholesterol, triglyceride, AST, ALT and urea levels were similar in the two groups (Table 1).[B] [U]Among the three subgroups of treatment, baseline values[/U] for BMI and age, biochemical parameters and [U]m[B]ean TV [/B]were also similar [/U](Table 1). Baseline vs post-treatment demographics, biochemical parameters, TS and TV [U]Subjects treated with TE were found to have significantly increased[/U] [/B]BMI, haemoglobin, haematocrit, triglyceride, TT, creatinine, TS and[B] [U]mean TV[/U], [/B]and decreased urea and HDL cholesterol levels by the 24th week (P < 0.05, for all) (Table 2; Fig. 1).[B][/B] Mean plasma triglyceride decreased,[B] [/B]whereas LH, TS and[B] [U]TV increased significantly after hCG treatment[/U] [/B](P < 0.05, for all) (Table 2; Fig. 1).[B] [/B]No significant changes in BMI or other biochemical parameters were observed in this group after 24 weeks. Application of TG was associated with a significant increase in TT level, but within the normal range. Besides, BMI, LH, TS and [U][B]mean TV increased[/B][/U][B], [/B]and total cholesterol and HDL cholesterol levels decreased significantly in the same subgroup (P < 0.05, for all). Other tested parameters were similar before and after treatment (Table 2). [B]Comparisons for the magnitude of the alterations in tested parameters among the study groups by the 24th week[/B] The number of changes in each tested parameter before and after the treatment was simply calculated by subtracting the pretreatment values from post-treatment ones. Then, intergroup differences were determined statistically (Table 3; Fig. 2). [B]The number of changes in each tested parameter before and after the treatment was simply calculated by subtracting the pretreatment values from post-treatment ones. Then, intergroup differences were determined statistically (Table 3; Fig. 2). [/B]Leucocyte count reduced in TG-treated individuals, while it was found increased in the other two treatment types, and the difference between the TG and TE groups was significant. Haematocrit count increased much lower in the hCG-treated group, which was significant when compared with TE-treated group. hCG treatment resulted in a decrease in plasma triglyceride level, whereas it was found higher in the other two groups, and the differences were significant. TG treatment caused a significant increase in FSH, LH and testosterone levels compared with TE treatment. Increase in testosterone level was significantly higher in the TG-treated group in comparison with the other two groups. Increase in TS was significantly higher in the TE and TG treatment groups. [B][U]Increase in TV was higher in the hCG group compared with both TE and TG groups[/U]; but, there was no difference between TE and TG groups regarding a change in TV.[/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Testicle Size: Testosterone Injections vs hCG vs T gel
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top